Supplemental material
Open access
2,300
Views
6
CrossRef citations to date
0
Altmetric
Oncology
Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US
Jason C. Allairea Generativity Health Economics and Outcomes Research, Durham, NC, USA;b Department of Psychology, North Carolina State University, Raleigh, NC, USA
, Mark Balkc BeiGene, Ltd., Emeryville, CA, USA
, Soraya Azmic BeiGene, Ltd., Emeryville, CA, USA
, Heather L. Handlc BeiGene, Ltd., Emeryville, CA, USA
, Keri Yangc BeiGene, Ltd., Emeryville, CA, USA
& Gisoo Barnesc BeiGene, Ltd., Emeryville, CA, USACorrespondence[email protected]
Pages 1403-1407
|
Received 12 Jan 2021, Accepted 10 May 2021, Published online: 03 Jun 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.